Literature DB >> 12489620

Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.

Don C Des Jarlais1, Courtney McKnight, Patricia Friedmann.   

Abstract

OBJECTIVE: To assess preliminary results of the Expanded Syringe Access Demonstration Program (ESAP) in New York City.
DESIGN: Temporal trends of pharmacy use among injection drug users (IDUs) in Brooklyn and Queens were analyzed from December 2000 through December 2001.
SETTING: Brooklyn and Queens, New York City. PARTIPANTS: IDUs. MAIN OUTCOME MEASURES: Attempts to purchase syringes from pharmacies and success in doing so.
RESULTS: Of the 1,072 IDUs interviewed from December 2000 through December 2001, the majority were daily heroin injectors, but there was also substantial speedball and cocaine injection. There was a clear increase over time in both the percentage of subjects who attempted to purchase syringes in pharmacies and in the percentage who successfully purchased syringes. Among IDUs interviewed 4 or more months after ESAP began, large majorities of those who attempted to purchase syringes were successful in doing so. No differences in use of ESAP by IDUs were identified in Brooklyn versus Queens: 27% of IDUs interviewed in Queens reported that they had attempted to purchase syringes in pharmacies versus 28% in Brooklyn. Persons who reported injecting on a daily or more frequent basis were more likely to have attempted pharmacy purchases than persons who reported injecting less frequently, 32% versus 21%.
CONCLUSIONS: The ESAP program has led to an increase in the use of pharmacies as sources of sterile injection equipment among IDUs in New York City. The extent to which pharmacies become an important source of sterile injection equipment and the effect of legal pharmacy sales on risk behaviors for human immunodeficiency virus (HIV) infection remain to be determined.

Entities:  

Mesh:

Year:  2002        PMID: 12489620     DOI: 10.1331/1086-5802.42.0.s73.de

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  7 in total

1.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

2.  Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.

Authors:  Hannah L F Cooper; Brian H Bossak; Barbara Tempalski; Samuel R Friedman; Don C Des Jarlais
Journal:  J Urban Health       Date:  2009-11       Impact factor: 3.671

3.  Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes.

Authors:  Hannah L F Cooper; Don C Des Jarlais; Zev Ross; Barbara Tempalski; Brian Bossak; Samuel R Friedman
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

4.  Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing.

Authors:  Samuel M Jenness; Holly Hagan; Kai-Lih Liu; Travis Wendel; Christopher S Murrill
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

5.  Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.

Authors:  Elise D Riley; Alex H Kral; Thomas J Stopka; Richard S Garfein; Paul Reuckhaus; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

6.  Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Don Des Jarlais
Journal:  J Urban Health       Date:  2009-11-18       Impact factor: 3.671

7.  Estimated effect of US state syringe sale policy on source of last-used injection equipment.

Authors:  Patrick Janulis; Barrett W Montgomery; James C Anthony
Journal:  Int J Drug Policy       Date:  2019-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.